Vestibular Migraine and POTS: Why They So Often Overlap

Vestibular migraine is the most common cause of episodic vertigo in adults, yet it remains dramatically underdiagnosed — particularly in patients who already carry a POTS diagnosis. The two conditions share so much pathophysiology that many researchers now consider them part of the same autonomic-neurological spectrum. Understanding the overlap is not merely academic: patients who have both conditions often find that treating one without addressing the other leads to persistent, baffling symptoms that no single specialist can explain.

What Is Vestibular Migraine?

Vestibular migraine (VM) is a neurological disorder in which migraine pathophysiology — cortical spreading depression, trigeminovascular activation, and central sensitization — produces vestibular symptoms rather than, or in addition to, headache. The International Headache Society diagnostic criteria require at least five episodes of vestibular symptoms of moderate or severe intensity lasting 5 minutes to 72 hours, a current or past history of migraine, and migraine features during at least 50% of vestibular episodes.

Vestibular symptoms include spontaneous vertigo (the room spinning without movement), positional vertigo, visually induced vertigo, head-motion-induced vertigo, and head-motion-induced nausea. Crucially, headache is absent in approximately 30% of VM episodes, which is why the condition is so frequently missed. Patients are often told they have "inner ear problems," benign paroxysmal positional vertigo (BPPV), or anxiety — the same diagnostic odyssey familiar to most POTS patients.

The Autonomic Connection

The vestibular system and the autonomic nervous system are deeply intertwined. The vestibular nuclei in the brainstem project directly to the nucleus tractus solitarius (NTS), the primary cardiovascular control center, and to the hypothalamus, which coordinates autonomic tone. This means that vestibular dysfunction does not merely cause dizziness — it actively disrupts heart rate, blood pressure, and vascular tone.

In POTS, the autonomic dysfunction runs in the opposite direction: impaired cardiovascular regulation produces orthostatic symptoms that secondarily destabilize the vestibular system. When a patient stands and their cerebral blood flow drops, the vestibular system — which depends on adequate perfusion — misfires, producing vertigo, oscillopsia (visual instability), and spatial disorientation that is indistinguishable from vestibular migraine.

The result is a bidirectional feedback loop. POTS destabilizes vestibular function; vestibular dysfunction amplifies autonomic dysregulation; and migraine pathophysiology — with its cortical hyperexcitability and trigeminovascular inflammation — sits at the center of both.

Shared Risk Factors

Several biological vulnerabilities predispose patients to both conditions simultaneously:

Connective tissue hypermobility. Hypermobile EDS and HSD are strongly associated with both POTS and vestibular migraine. Lax connective tissue in the cervical spine can compress vertebral arteries and destabilize the craniocervical junction, impairing both autonomic and vestibular function. Many VM+POTS patients have undiagnosed hEDS.

Mast cell activation. Mast cells are abundant in the dura mater and the inner ear. When activated, they release histamine, prostaglandins, and substance P — all of which lower the migraine threshold and increase vestibular sensitivity. MCAS patients frequently report that their worst VM episodes coincide with mast cell flares.

Estrogen fluctuation. Both POTS and vestibular migraine are dramatically more common in women of reproductive age, and both worsen with hormonal shifts — menstruation, perimenopause, and hormonal contraceptives. Estrogen modulates serotonin receptors, CGRP expression, and autonomic tone simultaneously.

Central sensitization. Chronic POTS produces central sensitization — a state of amplified neural signaling — that lowers the threshold for migraine. Conversely, chronic migraine produces central sensitization that amplifies orthostatic symptoms.

Diagnostic Challenges

The most common misdiagnosis in VM+POTS patients is BPPV. BPPV is caused by displaced otoliths in the semicircular canals and produces brief (< 1 minute) positional vertigo that resolves with the Epley maneuver. VM produces longer-duration vertigo that is not reliably triggered by specific head positions and does not resolve with repositioning maneuvers. If a patient has been told they have "recurrent BPPV" that keeps coming back despite Epley maneuvers, vestibular migraine is almost certainly the correct diagnosis.

Patients should also be evaluated for cervicogenic dizziness (dizziness originating from the cervical spine), which is common in hEDS and can mimic both VM and POTS. A skilled physical therapist with vestibular training can usually distinguish these clinically.

Treatment Approaches

Managing VM+POTS requires addressing both conditions simultaneously. Treating only one typically produces partial improvement at best.

POTS management first. Improving orthostatic tolerance — through volume expansion, compression, exercise rehabilitation, and appropriate medications — often reduces VM frequency significantly. Many patients find that their "vestibular migraines" become much less frequent once their POTS is better controlled, because adequate cerebral perfusion stabilizes the vestibular system.

Migraine-specific prevention. Beta-blockers (propranolol, metoprolol) are first-line for both POTS and migraine prevention — a convenient overlap. Topiramate and valproate are effective migraine preventives but require careful monitoring in POTS patients due to their effects on blood pressure and sodium. Amitriptyline at low doses (10–25 mg) is effective for both VM prevention and central sensitization. The newer CGRP antagonists (erenumab, fremanezumab, galcanezumab) are highly effective for VM and do not worsen POTS.

Vestibular rehabilitation. Vestibular physical therapy — specifically habituation exercises and gaze stabilization training — reduces VM frequency and severity by recalibrating the vestibular-ocular reflex. This is underutilized in VM+POTS patients but has strong evidence.

Mast cell stabilization. In patients with concurrent MCAS, aggressive mast cell management (H1/H2 antihistamines, cromolyn, ketotifen, low-histamine diet) often produces dramatic improvement in VM frequency.

Trigger management. VM triggers overlap substantially with POTS triggers: dehydration, sleep deprivation, hormonal shifts, barometric pressure changes, strong odors, and bright/flickering lights. A unified trigger diary helps patients identify patterns across both conditions.

What to Tell Your Doctor

If you have POTS and suspect vestibular migraine, ask for a referral to a neurologist or neurotologist with vestibular expertise. Bring a symptom diary documenting the duration, triggers, and associated features of your vestibular episodes. The key diagnostic question is: do your episodes last more than one minute and involve migraine features (light sensitivity, sound sensitivity, nausea, visual aura)? If yes, VM is highly likely.

The ChatDys AI can help you document your vestibular symptoms, identify patterns in your health tracker data, and generate a structured summary for your neurologist appointment.